This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Incyte (INCY), Pharvaris (PHVS)

Tipranks - Tipranks - Tue Jun 16, 8:17AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Incyte (INCY) and Pharvaris (PHVS) with bullish sentiments.

Claim 55% Off TipRanks

Incyte (INCY)

TD Cowen analyst Marc Frahm maintained a Buy rating on Incyte today and set a price target of $124.00. The company’s shares closed last Friday at $108.53.

According to TipRanks.com, Frahm is a 5-star analyst with an average return of 19.9% and a 51.3% success rate. Frahm covers the Healthcare sector, focusing on stocks such as Black Diamond Therapeutics, Acrivon Therapeutics, Inc., and Monte Rosa Therapeutics. ;'>

Incyte has an analyst consensus of Moderate Buy, with a price target consensus of $111.87, which is a 3.7% upside from current levels. In a report issued on June 8, TipRanks – Anthropic also upgraded the stock to Buy with a $114.00 price target.

See today’s best-performing stocks on TipRanks >>

Pharvaris (PHVS)

In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Pharvaris, with a price target of $41.00. The company’s shares closed last Friday at $30.72.

According to TipRanks.com, Skor is a 4-star analyst with an average return of 15.6% and a 61.5% success rate. Skor covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Monopar Therapeutics Inc, and Crispr Therapeutics AG. ;'>

Currently, the analyst consensus on Pharvaris is a Strong Buy with an average price target of $49.10, a 51.9% upside from current levels. In a report issued on June 11, JonesTrading also maintained a Buy rating on the stock with a $52.00 price target.

Read More on INCY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).